CD19 and Splenomegaly: Engrafted CMML#1-MN1 cells had a myeloid phenotype expressing CD33, CD38, and CD123, but lacked expression of lymphoid markers CD3 and CD19 (Supplementary Fig. S1D), and developed splenomegaly (Fig. 2c).